- 专利标题： TRANSDERMAL FORMULATIONS FOR DELIVERY OF CELECOXIB AND ITS USE IN THE TREATMENT OF CELECOXIB-RESPONSIVE DISEASES AND CONDITIONS
-
申请号： US16300116申请日： 2017-05-16
-
公开(公告)号： US20190142738A1公开(公告)日： 2019-05-16
- 发明人: Joseph Gabriele , Mikaela Teris
- 申请人： DELIVRA INC.
- 国际申请： PCT/CA2017/050585 WO 20170516
- 主分类号： A61K9/00
- IPC分类号： A61K9/00 ; A61K31/635 ; A61K9/107 ; A61K47/14 ; A61K47/44 ; A61K47/30 ; A61K47/46 ; A61K47/24 ; A61K9/06 ; A61K47/22
摘要：
The present application is directed to transdermal formulations for the delivery of celecoxib to a subject for the treatment of celecoxib-responsive diseases or conditions. In particular, the transdermal formulation is an emulsion comprising an oil phase, an aqueous phase and an external phase.
信息查询
